Global Generic Injectable Drugs Market Research Report 2023(Status and Outlook)

Global Generic Injectable Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.

The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.

The Global Generic Injectable Drugs Market Size was estimated at USD 30610.00 million in 2022 and is projected to reach USD 38944.47 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Generic Injectable Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Generic Injectable Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Generic Injectable Drugs market in any manner.

Global Generic Injectable Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hospira (Pfizer Inc.)

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Market Segmentation (by Type)

Small Molecule

Large Molecule

Market Segmentation (by Application)

Home Appliances

Industrial

Automotive

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Generic Injectable Drugs Market

Overview of the regional outlook of the Generic Injectable Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Generic Injectable Drugs
1.2 Key Market Segments
1.2.1 Generic Injectable Drugs Segment by Type
1.2.2 Generic Injectable Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Generic Injectable Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Generic Injectable Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Generic Injectable Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Generic Injectable Drugs Market Competitive Landscape
3.1 Global Generic Injectable Drugs Sales by Manufacturers (2018-2023)
3.2 Global Generic Injectable Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Generic Injectable Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Generic Injectable Drugs Sales Sites, Area Served, Product Type
3.6 Generic Injectable Drugs Market Competitive Situation and Trends
3.6.1 Generic Injectable Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Generic Injectable Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Generic Injectable Drugs Industry Chain Analysis
4.1 Generic Injectable Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Generic Injectable Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Generic Injectable Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Generic Injectable Drugs Sales Market Share by Type (2018-2023)
6.3 Global Generic Injectable Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Generic Injectable Drugs Price by Type (2018-2023)
7 Generic Injectable Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Generic Injectable Drugs Market Sales by Application (2018-2023)
7.3 Global Generic Injectable Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Generic Injectable Drugs Sales Growth Rate by Application (2018-2023)
8 Generic Injectable Drugs Market Segmentation by Region
8.1 Global Generic Injectable Drugs Sales by Region
8.1.1 Global Generic Injectable Drugs Sales by Region
8.1.2 Global Generic Injectable Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Generic Injectable Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Generic Injectable Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Generic Injectable Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Generic Injectable Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Generic Injectable Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Hospira (Pfizer Inc.)
9.1.1 Hospira (Pfizer Inc.) Generic Injectable Drugs Basic Information
9.1.2 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Overview
9.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Market Performance
9.1.4 Hospira (Pfizer Inc.) Business Overview
9.1.5 Hospira (Pfizer Inc.) Generic Injectable Drugs SWOT Analysis
9.1.6 Hospira (Pfizer Inc.) Recent Developments
9.2 Fresenius Kabi
9.2.1 Fresenius Kabi Generic Injectable Drugs Basic Information
9.2.2 Fresenius Kabi Generic Injectable Drugs Product Overview
9.2.3 Fresenius Kabi Generic Injectable Drugs Product Market Performance
9.2.4 Fresenius Kabi Business Overview
9.2.5 Fresenius Kabi Generic Injectable Drugs SWOT Analysis
9.2.6 Fresenius Kabi Recent Developments
9.3 Sandoz (Novartis)
9.3.1 Sandoz (Novartis) Generic Injectable Drugs Basic Information
9.3.2 Sandoz (Novartis) Generic Injectable Drugs Product Overview
9.3.3 Sandoz (Novartis) Generic Injectable Drugs Product Market Performance
9.3.4 Sandoz (Novartis) Business Overview
9.3.5 Sandoz (Novartis) Generic Injectable Drugs SWOT Analysis
9.3.6 Sandoz (Novartis) Recent Developments
9.4 Hikma Pharmaceuticals PLC
9.4.1 Hikma Pharmaceuticals PLC Generic Injectable Drugs Basic Information
9.4.2 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Overview
9.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Market Performance
9.4.4 Hikma Pharmaceuticals PLC Business Overview
9.4.5 Hikma Pharmaceuticals PLC Generic Injectable Drugs SWOT Analysis
9.4.6 Hikma Pharmaceuticals PLC Recent Developments
9.5 Dr. Reddy’s Laboratories Ltd
9.5.1 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Basic Information
9.5.2 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Overview
9.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Market Performance
9.5.4 Dr. Reddy’s Laboratories Ltd Business Overview
9.5.5 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs SWOT Analysis
9.5.6 Dr. Reddy’s Laboratories Ltd Recent Developments
9.6 Grifols
9.6.1 Grifols Generic Injectable Drugs Basic Information
9.6.2 Grifols Generic Injectable Drugs Product Overview
9.6.3 Grifols Generic Injectable Drugs Product Market Performance
9.6.4 Grifols Business Overview
9.6.5 Grifols Recent Developments
9.7 Nichi-Iko Group (Sagent)
9.7.1 Nichi-Iko Group (Sagent) Generic Injectable Drugs Basic Information
9.7.2 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Overview
9.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Market Performance
9.7.4 Nichi-Iko Group (Sagent) Business Overview
9.7.5 Nichi-Iko Group (Sagent) Recent Developments
9.8 Teva Pharmaceutical
9.8.1 Teva Pharmaceutical Generic Injectable Drugs Basic Information
9.8.2 Teva Pharmaceutical Generic Injectable Drugs Product Overview
9.8.3 Teva Pharmaceutical Generic Injectable Drugs Product Market Performance
9.8.4 Teva Pharmaceutical Business Overview
9.8.5 Teva Pharmaceutical Recent Developments
9.9 Auromedics
9.9.1 Auromedics Generic Injectable Drugs Basic Information
9.9.2 Auromedics Generic Injectable Drugs Product Overview
9.9.3 Auromedics Generic Injectable Drugs Product Market Performance
9.9.4 Auromedics Business Overview
9.9.5 Auromedics Recent Developments
9.10 Sanofi
9.10.1 Sanofi Generic Injectable Drugs Basic Information
9.10.2 Sanofi Generic Injectable Drugs Product Overview
9.10.3 Sanofi Generic Injectable Drugs Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Gland Pharma
9.11.1 Gland Pharma Generic Injectable Drugs Basic Information
9.11.2 Gland Pharma Generic Injectable Drugs Product Overview
9.11.3 Gland Pharma Generic Injectable Drugs Product Market Performance
9.11.4 Gland Pharma Business Overview
9.11.5 Gland Pharma Recent Developments
9.12 Endo International PLC
9.12.1 Endo International PLC Generic Injectable Drugs Basic Information
9.12.2 Endo International PLC Generic Injectable Drugs Product Overview
9.12.3 Endo International PLC Generic Injectable Drugs Product Market Performance
9.12.4 Endo International PLC Business Overview
9.12.5 Endo International PLC Recent Developments
10 Generic Injectable Drugs Market Forecast by Region
10.1 Global Generic Injectable Drugs Market Size Forecast
10.2 Global Generic Injectable Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Generic Injectable Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Generic Injectable Drugs Market Size Forecast by Region
10.2.4 South America Generic Injectable Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Generic Injectable Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Generic Injectable Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Generic Injectable Drugs by Type (2024-2029)
11.1.2 Global Generic Injectable Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Generic Injectable Drugs by Type (2024-2029)
11.2 Global Generic Injectable Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Generic Injectable Drugs Sales (K Units) Forecast by Application
11.2.2 Global Generic Injectable Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings